par Hendlisz, Alain ;Van Den Eynde, Marc;Peeters, Marc;Maleux, G;Lambert, Bieke;Vannoote, Jaarke;De Keukeleire, Katrien;Verslype, Chris;Defreyne, L;Van Cutsem, Eric;Delatte, Philippe ;Delaunoit, Thierry ;Personeni, Nicola;Paesmans, Marianne ;Van Laethem, Jean-Luc ;Flamen, Patrick
Référence Journal of clinical oncology, 28, 23, page (3687-3694)
Publication Publié, 2010-08
Référence Journal of clinical oncology, 28, 23, page (3687-3694)
Publication Publié, 2010-08
Article révisé par les pairs
Titre: |
|
Auteur: | Hendlisz, Alain; Van Den Eynde, Marc; Peeters, Marc; Maleux, G; Lambert, Bieke; Vannoote, Jaarke; De Keukeleire, Katrien; Verslype, Chris; Defreyne, L; Van Cutsem, Eric; Delatte, Philippe; Delaunoit, Thierry; Personeni, Nicola; Paesmans, Marianne; Van Laethem, Jean-Luc; Flamen, Patrick |
Informations sur la publication: | Journal of clinical oncology, 28, 23, page (3687-3694) |
Statut de publication: | Publié, 2010-08 |
Sujet CREF: | Sciences bio-médicales et agricoles |
MeSH keywords: | Adenocarcinoma -- secondary -- therapy |
Aged, 80 and over | |
Antineoplastic Agents, Alkylating -- administration & dosage | |
Colorectal Neoplasms -- pathology -- therapy | |
Embolization, Therapeutic | |
Female | |
Fluorouracil -- administration & dosage | |
Humans | |
Infusions, Intravenous | |
Injections, Intra-Arterial | |
Liver Neoplasms -- secondary -- therapy | |
Male | |
Microspheres | |
Middle Aged | |
Prospective Studies | |
Treatment Outcome | |
Yttrium Radioisotopes -- administration & dosage | |
Note générale: | Clinical Trial, Phase III |
Comparative Study | |
Journal Article | |
Multicenter Study | |
Randomized Controlled Trial | |
Research Support, Non-U.S. Gov't | |
Langue: | Anglais |
Identificateurs: | urn:issn:0732-183X |
info:doi/10.1200/JCO.2010.28.5643 | |
info:pii/JCO.2010.28.5643 | |
info:pmid/20567019 |